Pherecydes Pharma SA
PAR:ALPHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pherecydes Pharma SA
PAR:ALPHE
|
FR |
|
Co-Diagnostics Inc
OTC:CODX
|
US |
|
B
|
Beijing Media Corp Ltd
XBER:BME
|
CN |
|
Cryptology Asset Group PLC
F:CAP
|
MT |
|
S
|
Sequa Petroleum NV
PAR:MLSEQ
|
UK |
|
PhaseBio Pharmaceuticals Inc
OTC:PHASQ
|
US |
|
R
|
Ruby Textile Mills Ltd
KAR:RUBY
|
PK |
Dividends
Dividend Yield
Pherecydes Pharma SA
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Pherecydes Pharma SA
ALPHE have decreased by 0%.
Payout Ratio
Pherecydes Pharma SA
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for ALPHE is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ALPHE Price
Pherecydes Pharma SA
| Average Annual Return | 1.13% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -77% |
| Market Capitalization | 15.9m EUR |
| Shares Outstanding | 7 953 810 |
| Percentage of Shares Shorted |
N/A
|
